Barclays PLC Horizon Therapeutics Public LTD CO Call Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $15.5 Million - $28.3 Million	248,600 New	248,600 $28.3 Million
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $33,220 - $62,678	-1,100 Reduced 47.83%	1,200 $67,000
Q1 2020 May 13, 2020	SELL	$24.87 - $38.56 $253,674 - $393,312	-10,200 Reduced 81.6%	2,300 $68,000
Q4 2019 Feb 10, 2020	SELL	$25.43 - $36.67 $20,344 - $29,336	-800 Reduced 6.02%	12,500 $453,000
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $110,400 - $134,256	-4,800 Reduced 26.52%	13,300 $362,000
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $412,861 - $515,488	18,100 New	18,100 $435,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.